KAOPECTATE CHEWABLE TABLETS 300MG
KAOPECTATE CHEWABLE TABLETS 300MG
Discontinued
DIN Number
02229948
Drug Class
Human
Market Date
Sep 18, 1998
Company
HC
johnson & johnson - merck consumer pharmaceuticals of canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02229948
AIG Number0111623004
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A07BC04 ATTAPULGITE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ATTAPULGITE (ACTIVATED)Active
Strength: 300 MG
Monograph: ATTAPULGITE (ACTIVATED)